Literature DB >> 16019758

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

Jonathan I Epstein1, Mahul Amin, Liliane Boccon-Gibod, Lars Egevad, Peter A Humphrey, Gregor Mikuz, Don Newling, Sten Nilsson, Wael Sakr, John R Srigley, Thomas M Wheeler, Rodolfo Montironi.   

Abstract

This paper, based on the activity of the Morphology-Based Prognostic Factors Committee of the 2004 World Health Organization-sponsored International Consultation, describes various methods of handling radical prostatectomy specimens for both routine clinical use and research purposes. The correlation between radical prostatectomy findings and postoperative failure is discussed in detail. This includes issues relating to pelvic lymph node involvement, detected both at the time of frozen section and in permanent sections. Issues of seminal vesicle invasion, including its definition, routes of invasion and relationship to prognosis, are covered in detail. The definition, terminology and incidence of extra-prostatic extension are elucidated, along with its prognostic significance relating to location and extent. Margins of resection are covered in terms of their definition, the etiology, incidence and sites of positive margins, the use of frozen sections to assess the margins and the relationship between margin positivity and prognosis. Issues relating to grade within the radical prostatectomy specimen are covered in depth, including novel ways of reporting Gleason grade and the concept of tertiary Gleason patterns. Tumor volume, tumor location, vascular invasion and perineural invasion are the final variables discussed relating to the prognosis of radical prostatectomy specimens. The use of multivariate analysis to predict progression is discussed, together with proposed modifications to the TNM system. Finally, biomarkers to predict progression following radical prostatectomy are described, including DNA ploidy, microvessel density, Ki-67, neuroendocrine differentiation, p53, p21, p27, Bcl-2, Her-2/neu, E-cadherin, CD44, retinoblastoma proteins, apoptotic index, androgen receptor status, expression of prostate-specific antigen and prostatic-specific acid phosphatase and nuclear morphometry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019758     DOI: 10.1080/03008880510030932

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  43 in total

1.  Prognostic factors identifying biochemical recurrence in patients with positive margins after radical prostatectomy.

Authors:  Ioannis Anastasiou; Stavros I Tyritzis; Ioannis Adamakis; Dionysios Mitropoulos; Konstantinos G Stravodimos; Ioannis Katafigiotis; Antonios Balangas; Anastasios Kollias; Kitty Pavlakis; Constantinos A Constantinides
Journal:  Int Urol Nephrol       Date:  2010-10-30       Impact factor: 2.370

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

3.  Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).

Authors:  Theodorus H van der Kwast; Laurence Collette; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi DaPozzo; Jean-François Bosset; Karl H Kurth; Fritz H Schröder; Michel Bolla
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

4.  Seminal vesicle invasion in radical prostatectomies: which is the most common route of invasion?

Authors:  Athanase Billis; Daniel A Teixeira; Rafael F Stelini; Maísa M Quintal; Marbele S Guimarães; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2007-03-13       Impact factor: 2.370

5.  Recommendations for the reporting of prostate carcinoma.

Authors:  Jonathan I Epstein; John Srigley; David Grignon; Peter Humphrey; Christopher Otis
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

Review 6.  [Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology].

Authors:  G Kristiansen; J R Srigley; B Delahunt; L Egevad
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

7.  Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability.

Authors:  Sven Gunia; Knut Albrecht; Stefan Koch; Thomas Herrmann; Thorsten Ecke; Volker Loy; Jörg Linke; Michael Siegsmund; Matthias May
Journal:  World J Urol       Date:  2008-04-05       Impact factor: 4.226

8.  The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

Authors:  A Karl; A Buchner; C Tympner; T Kirchner; U Ganswindt; C Belka; R Ganzer; M Burger; F Eder; F Hofstädter; D Schilling; K Sievert; A Stenzl; M Scharpf; F Fend; F Vom Dorp; H Rübben; K Schmid; D Porres-Knoblauch; A Heidenreich; B Hangarter; R Knüchel-Clarke; M Rogenhofer; B Wullich; A Hartmann; E Comploj; A Pycha; E Hanspeter; D Pehrke; G Sauter; M Graefen; C Stief; A Haese
Journal:  World J Urol       Date:  2015-02-15       Impact factor: 4.226

9.  Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.

Authors:  Antoun Toubaji; Roula Albadine; Alan K Meeker; William B Isaacs; Tamara Lotan; Michael C Haffner; Alcides Chaux; Jonathan I Epstein; Misop Han; Patrick C Walsh; Alan W Partin; Angelo M De Marzo; Elizabeth A Platz; George J Netto
Journal:  Mod Pathol       Date:  2011-07-08       Impact factor: 7.842

10.  Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy.

Authors:  Sung-Woo Park; Nathaniel Readal; Byong Chang Jeong; Elizabeth B Humphreys; Jonathan I Epstein; Alan W Partin; Misop Han
Journal:  Eur Urol       Date:  2014-07-31       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.